Schedule 13G ownership disclosure

AUTOLUS THERAPEUTICS LTD

Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share. · CUSIP: 05280R100

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Syncona Portfolio Limited

    Shares: 28,821,053 · Class: 10.8%

  • Syncona Holdings Limited

    Shares: 28,821,053 · Class: 10.8%

  • Syncona Investment Management Limited

    Shares: 28,821,053 · Class: 10.8%

  • Syncona Limited

    Shares: 28,821,053 · Class: 10.8%

  • Roel Bulthuis

    Shares: 28,821,053 · Class: 10.8%

  • Christopher Hollowood

    Shares: 28,821,053 · Class: 10.8%

  • Kenneth Galbraith

    Shares: 28,821,053 · Class: 10.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-065100
Form type
SCHEDULE 13G/A
Filer
Autolus Therapeutics plc
CIK
CIK 1730463
Filed
May 07, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub